Company
About us
Acticor Team
Board of Directors
investors & Partners
Prizes & Awards
Our Product
Our product: Glenzocimab
GPVI / GLENZOCIMAB in brief
in acute ischemic stroke
in STEMI
in other indications
Pipeline
About
Key figures
What is a stroke?
Media
Press Releases
Publications
Media Coverage
Events
Investors
Welcome
Corporate Presentation
Share Overview
Shareholders' Meeting
Regulated Information
Financial Agenda
COntact
Investors
Events
October 6, 2022
Investor Access – Oct. 6-7, 2022: Meet Acticor Biotech at the next Investor Access
Meet Acticor Biotech at the next Investor Access
